Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Reich

Showing results (11-20 of 316) with videos related to

Pageof 32
Sort By:
Biomed Research International|November 29, 2021
The Significance of Autoantibodies in Juvenile DermatomyositisDominika Kwiatkowska, Adam Reich
Acta Dermatovenerologica Croatica : ADC|July 29, 2019
High Body Mass Index is a Risk Factor for Acne Severity in Adolescents: A Preliminary ReportKarolina Sas, Adam Reich
The British Journal of Dermatology|July 7, 2023
Seeking new topical therapies in psoriasisDominika Kwiatkowska, Adam Reich
The British Journal of Dermatology|September 9, 2025
Could tyrosine kinase 2 inhibition be a breakthrough in the effective treatment of cutaneous lupus erythematosus?Dominik Samotij, Adam Reich
The British Journal of Dermatology|March 11, 2025
Breaking the Itch Cycle: Long-Term effects of Nemolizumab in Prurigo NodularisKamila Kędra, Adam Reich
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|October 31, 2007
[Genetic and immunological aspects of the pathogenesis of psoriasis]Adam Reich, Jacek Szepietowski
Journal of Clinical Medicine|July 27, 2022
Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in CaucasiansMagdalena Żychowska, Adam Reich
Dermatology (Basel, Switzerland)|May 12, 2017
Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGAAgnieszka Bożek, Adam Reich
The Journal of Investigative Dermatology|August 2, 2025
A Paradigm Shift in the Pathophysiology and Treatment of Chronic Kidney Disease-Associated PruritusKamila Kędra, Adam Reich
The British Journal of Dermatology|December 1, 2025
Are we missing true therapeutic outcomes in hidradenitis suppurativa by using HiSCR? A lesson learned from the SHINE trialDominik Samotij, Adam Reich
Pageof 32

Showing results (11-20 of 316) with videos related to

Sort By:
Pageof 32
Biomed Research International|November 29, 2021
The Significance of Autoantibodies in Juvenile DermatomyositisDominika Kwiatkowska, Adam Reich
Acta Dermatovenerologica Croatica : ADC|July 29, 2019
High Body Mass Index is a Risk Factor for Acne Severity in Adolescents: A Preliminary ReportKarolina Sas, Adam Reich
The British Journal of Dermatology|July 7, 2023
Seeking new topical therapies in psoriasisDominika Kwiatkowska, Adam Reich
The British Journal of Dermatology|September 9, 2025
Could tyrosine kinase 2 inhibition be a breakthrough in the effective treatment of cutaneous lupus erythematosus?Dominik Samotij, Adam Reich
The British Journal of Dermatology|March 11, 2025
Breaking the Itch Cycle: Long-Term effects of Nemolizumab in Prurigo NodularisKamila Kędra, Adam Reich
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|October 31, 2007
[Genetic and immunological aspects of the pathogenesis of psoriasis]Adam Reich, Jacek Szepietowski
Journal of Clinical Medicine|July 27, 2022
Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in CaucasiansMagdalena Żychowska, Adam Reich
Dermatology (Basel, Switzerland)|May 12, 2017
Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGAAgnieszka Bożek, Adam Reich
The Journal of Investigative Dermatology|August 2, 2025
A Paradigm Shift in the Pathophysiology and Treatment of Chronic Kidney Disease-Associated PruritusKamila Kędra, Adam Reich
The British Journal of Dermatology|December 1, 2025
Are we missing true therapeutic outcomes in hidradenitis suppurativa by using HiSCR? A lesson learned from the SHINE trialDominik Samotij, Adam Reich
Pageof 32